Abstract
Magnus Glindvad Ahlström, Andreas Ronit, Børge Grønne Nordestgaard, Shoaib Afzal
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe
10.1111/1469-0691.12195 · 2013
Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study
10.1093/cid/ciq069 · 2011
Global burden of chronic obstructive pulmonary disease through 2050
10.1001/jamanetworkopen.2023.46598 · 2023
Chronic obstructive pulmonary disease and risk of infection
10.5603/arm.27817 · 2009
The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults
10.1086/431521 · 2005
Respiratory viral infections in adults with and without chronic obstructive pulmonary disease
10.1164/ajrccm.162.1.9911019 · 2000
Population-based risk factors for community-onset bloodstream infections
10.1007/s10096-019-03777-8 · 2020
Increased incidence of invasive bacterial disease in chronic obstructive pulmonary disease compared to the general population-a population based cohort study
10.1186/1471-2334-14-163 · 2014
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
10.1001/jama.298.3.299 · 2007
The danish microbiology database (MIBA) 2010 to 2013
10.2807/1560-7917.es2014.19.1.20667 · 2014
Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study
10.1093/eurheartj/ehz327 · 2019
ERS Task force to establish improved lung function reference values, includng supplement
10.1183/09031936.00080312 · 2013
New Creatinine- and cystatin C–Based equations to estimate GFR without race
10.1056/nejmoa2102953 · 2021
Cox's regression model for counting processes: a large sample study
10.1214/aos/1176345976 · 1982
10.1183/09031936.03.00405703
10.1183/09031936.03.00405703
The nature of small-airway obstruction in chronic obstructive pulmonary disease
10.1056/nejmoa032158 · 2004
Systemic markers of adaptive and innate immunity are associated with chronic obstructive pulmonary disease severity and spirometric disease progression
10.1165/rcmb.2017-0373oc · 2018
Systemic manifestations and comorbidities of COPD
10.1183/09031936.00128008 · 2009
New insights into the immunology of chronic obstructive pulmonary disease
10.1016/s0140-6736(11)60988-4 · 2011
Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta 2 agonists
10.18632/aging.102217 · 2019
Unresolved referenced work
2000
Pneumococcal pneumonia presenting with septic shock: Host- and pathogen-related factors and outcomes
10.1136/thx.2009.123612 · 2010
Smoking and alcohol abuse are the most preventable risk factors for invasive pneumonia and other pneumococcal infections
10.1016/j.ijid.2013.12.013 · 2014
COPD stage and risk of hospitalization for infectious disease
10.1378/chest.07-2933 · 2008
Information bias
2007
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
10.1016/s0140-6736(18)30206-x · 2018
Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis
10.1186/s12931-017-0683-x · 2017
Unresolved referenced work
2014
Klebsiella pneumoniae bioconjugate vaccine functional durability in mice
2024
Preclinical validation of an Escherichia coli O-antigen glycoconjugate for the prevention of serotype O1 invasive disease
10.1128/spectrum.04213-23 · 2024
Klebsiella pneumoniae lipopolysaccharide as a vaccine target and the role of antibodies in protection from disease
10.3390/vaccines12101177 · 2024
No additional external references are available.